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Implications for Patient Care 
 Use of a second radiology reader in breast cancer screening can increase the number of 
cancers detected, however the clinical importance of these requires careful 
consideration as some may be overdiagnosed.  
 The additional cancers detected by only the second reader were more likely to be ductal 
carcinoma in situ and lower grade tumors. 
 Double reading with arbitration of discordant examinations recalled fewer women for 
further tests than would have been recalled if only the first reader decision was used. 
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 Use of effective arbitration of discordant examinations can reduce the number of 
women recalled for further tests.  
 
 
Summary statement: 
Double reading decreases recall rates and increases cancer detection rates in the English Breast 
Screening Programme, but the extra cancers detected are smaller, lower grade and less likely 
to have nodal involvement. 
 
 
 
 
 
Abstract  
Purpose 
To investigate the effect of double readings by a second radiologist on recall rates, cancer 
detection and characteristics of cancers detected in the National Health Service Breast 
Screening Program in England.  
 
Materials and Methods 
In this retrospective analysis we evaluated 805,206 women through screening and 
diagnostic test results by extracting one year of routine data from 33 English breast screening 
centers. Centers used double reading of digital mammograms, with arbitration if there were 
discrepant reads. Information on reader decisions, with results of follow-up tests, were used to 
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explore the effect of the second reader. The statistical tests used were the test for equality of 
proportions, the χ2 test for independence and the t-test. 
 
Results 
The first reader recalled 4·76%, (38295/805206, 95% CI 4·71%-4·80%) of women. Two 
readers recalled 6·19% in total, (49857/805206, 95% CI 6·14%- 6·24%), but arbitration of 
discordant reads reduced recall rate to 4·08%, (32863/805206, 95% CI 4·04%-4·12%, 
p<0.001). 7055 cancers were detected of which 627 (8·89%, 95% CI 8·22%-9·55%, p<0.001) 
were detected by the second reader only. These additional cancers were more likely to be ductal 
carcinoma in situ, (30·5% (183/600) vs 22.0% (1344/6114), p<0.001); and additional invasive 
cancers were smaller (mean 14·2mm vs 16·7mm, p<0.001), had fewer involved nodes, and 
were likely to be lower grade. 
 
Conclusion 
Double reading with arbitration reduces recall and increases cancer detection compared to 
single reading. Cancers detected only by the second reader were smaller, lower grade, and had 
less nodal involvement.  
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Introduction 
Breast cancer is a leading cause of cancer in women (1), and many countries have implemented 
screening programs. Despite concerns about the balance of benefits and harms of these 
programs, randomised controlled trials (RCTs) indicate that screening reduces mortality from 
breast cancer (2, 3).  
In many European Countries, screening of mammograms is conducted by two readers. 
Recall occurs if 1) either reader suggests it, 2) through consensus, or 3) following arbitration 
by a third, or more, additional readers (4, 5). In the United States, mammograms are typically 
interpreted by a single reader accompanied by computer aided detection (6). There is debate 
about the benefits and costs of single versus double reader programs. Some film mammography 
studies indicate that double reading increases the number of cancers detected (7-12), but recalls 
more women (9, 11-14) and requires more resources (15). It might increase detection of small 
(<15mm) cancers (16), and identify a higher ratio of ductal carcinoma in situ (DCIS) to invasive 
cancers (15), which is potentially undesirable due to the association between DCIS and 
overdiagnosis (17, 18). Other studies report no differences in the size or stage of cancers 
between single and double reader programs (9, 19).  
Digital mammography has replaced film mammography in routine clinical practice (20, 
21). Yet despite the widespread use of digital mammography and double reading, there is little 
published data on their combined effects. Three small studies, and a meta-analysis of these 
studies, found no statistically significant difference in cancer detection rates between single 
and double reader strategies (22-25). Extra cancers identified by second readers were more 
likely to be DCIS than invasive carcinomas (23). Posso and colleagues have tentatively 
suggested that single reader screening could reduce costs in breast cancer programs without 
decreasing cancer detection rates (23, 24). However, results may be because of small sample 
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sizes, as the second reader detected an extra 10% (n=24) cancers, but it was not statistically 
significant (24). 
The key limitations of the evidence-base are that most data come from film 
mammography studies (which does not reflect modern breast screening), and that those using 
digital mammography have had relatively small samples (maximum = 57157) and detected few 
cancers (limiting their power to detect differences). Our purpose was to examine the impact of 
double reading on recall and cancer detection rates, and the characteristics of the additional 
cancers identified by double reading in the National Health Service Breast Screening Program 
in England.  
 
Methods 
Study design and participants 
This is a population based cohort study nested within the Changing case Order to 
Optimise patterns of Performance in Screening (CO-OPS)  Trial, which included 1,194,147 
women aged between 47 and 73, at 46 screening centers, all between December 20, 2012, and 
November 3, 2014 (26). [ISRCTN46603370, ethical approvals: Coventry and Warwickshire 
National Health Service (NHS) Research Ethics Committee, June 27, 2012, WM/0182]. Each 
center participated for a year, and every woman screened as part of the United Kingdom 
National Health Service population breast screening program was included in this study. 
Women presenting symptomatically or tested because of familial or other risk factors were 
excluded. In this cohort study we analysed data from 33 centers: 13 centers were excluded 
because they used arbitration after both readers agreed to recall.  805,665 women were included 
in the analysis, all of which have previously been reported in an analysis of radiologist 
performance with time on task (25) but none have previously been reported in a comparison of 
single and double reading. 
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Procedures 
In the UK, women aged 50-70 are invited to mammography screening every 3 years, 
with a trial of age extension from 47-73 years. Two views of each breast are taken, mediolateral 
oblique and craniocaudal. Mammograms are reviewed by two readers from the same breast 
screening center using digital mammography without computer aided detection. They are 
instructed to read batches of women’s mammograms independently, but can view the other 
readers’ decision via patient records. They are aware whether they are the first or second reader 
from the workflow processes.  12 out of 33 centers employed workflow systems designed to 
blind the second reader to the decision of the first reader. Disagreements between readers were 
resolved either through a single third reader (n = 11 centers) or by group consensus (n = 22 
centers) arbitration. Arbitration was undertaken by qualified readers from the same screening 
center. All readers were accredited by the National Health Service Breast Screening 
Programme; readers undergo formal training, read a minimum of 5000 women’s mammograms 
per year, participate in assessment clinics, audit their own performance, and maintain 
continuing professional development (4). Each service is expected to perform within set 
parameters including cancer detection and recall rates (27). Readers take 35 seconds on average 
to examine each woman’s digital mammograms in the NHS Breast Screening Programme. (28) 
Women recalled from screening are offered further tests at assessment, according to national 
guidelines. (29) 
 
Outcomes 
The main outcomes were recall and cancer detection rates. Cancer was defined as 
histologically confirmed invasive cancer or DCIS. Absence of cancer was confirmed either 
through arbitration by expert readers, or follow up tests including ultrasound, MRI and biopsy.  
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Where three year follow-up data were available, (for women attending 10 of the first centers 
to complete the trial), interval cancer rates between screening rounds and cancer detection rates 
at the following screening were measured as an alternative reference standard to determine 
absence of cancer. Secondary outcomes were characteristics of cancers detected, specifically 
the proportion that included any invasive cancer (rather than DCIS only), the grade, number of 
involved nodes, and pathological size for women with invasive cancer, and the grade for 
women with only DCIS.  
 
Data Collection 
Data were extracted from the National Breast Screening Service electronic database. 
We extracted the decisions of the first and second reader, (and arbitration where used) for 
whether the case should be recalled for further tests, which are recorded automatically at the 
point of making the decision. The decision of arbitration was final, and to confirm this we 
checked against records scheduling the follow-up appointments. For all follow-up 
appointments, we extracted whether the woman had a biopsy, the biopsy result (pathology), 
and the result of other follow-up tests used (additional mammography, clinical breast 
examination, ultrasound and/or MRI). We extracted pathology results following any 
subsequent surgery. This was used to confirm biopsy results, and report grade, size and number 
of involved nodes. We extracted interval cancer rates between screening rounds and cancer 
detection rates at the following screening round three years later for women attending 10 of the 
first centers to complete the trial, as in these centers sufficient time has elapsed to extract these 
data. This was used to investigate whether women with discordant reads who were not recalled 
after arbitration were at increased risk for later cancer detection, (which may be an indication 
of errors in arbitration and potential underestimation of the extra cancers detected by the second 
reader).  
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Statistical analysis 
The analysis compared recall rate from three screening approaches. The first (double 
reading plus arbitration) was what was used in clinical practice. Two readers independently 
examine each case, and indicate whether they think the woman should be recalled for further 
tests. If they disagree then expert arbitration is used to make the final decision. The second 
approach (single reader) derives results from whether the first reader alone adjudged that the 
woman should be recalled. The third (recall if either reader suggests) counts every woman 
recalled by either reader as recalled.  
The number of cancers detected by double reading plus arbitration was compared to the 
number detected by reader one alone.  
The characteristics of the extra cancers detected by the second reader alone (missed by 
the first reader) were compared to those cancers detected by reader one. Number of involved 
nodes were grouped into none, 1-2, and 3 or more as these categories relate to prognosis. The 
statistical tests used were the test for equality of proportions, the χ2 test for independence and 
the t-test. We undertook a sensitivity analysis assuming all missing data were extreme cases 
(invasive disease not present, lowest grade, without nodal involvement or vice versa). The 
analysis was performed using R statistical software, version 3.4.1 , in RStudio, version 1.0.153 
(30). For women at 10 of the first centers to complete the trial, we report three year interval 
cancer rate and cancer detection rate at their subsequent screen three years later. This divided 
into three groups: women who were recalled by the first reader but not by the second reader 
and arbitration at the current screen, women who were recalled by the second reader but not by 
the first reader and arbitration at the current screen, and all other women who were not recalled 
at the current screen (recalled by neither reader). Comparisons between these groups were 
made using the test for equality of proportions. If women who had a discordant read but were 
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not recalled at the current round have a higher cancer detection rate in the subsequent round 
this may indicate that arbitration was incorrect and cancers were missed at the current round. 
However, it may also be caused by discordant cases having other risk factors for developing 
cancers between screening rounds, such as increased breast density. As a sensitivity analysis 
the number of additional cancers detected by the second reader was recalculated assuming that 
the difference between cancer detection rate in discordant and non-discordant reads at the 
subsequent round is due entirely to cancers missed by arbitration at the current round, and that 
the differences at the 10 centers would not differ from those across the whole dataset.  
 
Results 
The flow of women through the study is detailed in figure 1. Of the 805,665 women screened, 
805,206 had complete records of first and second reader screening decisions. 459 (0.1%) were 
excluded from further analysis as 44 were examined by a single reader only and recalled for 
further tests, and 425 were examined by a single reader only and not recalled for further tests. 
All women had complete records for whether they were recalled for further tests, and whether 
the results of those further tests showed any type of cancer (DCIS or invasive). Median age of 
women included was 59 (IQR 53 to 65), and 169753 (21·1%) were attending their first ever 
screening appointment.  
In total 7055 cancers were detected. Details of missing data are provided in table 1. 
Excluding missing data, invasive disease was present in 77·3% (5190/6717) of cancers, of 
which 20·4% (1048/5147) were Grade 3, 54·3% (2797/5147) were Grade 2 and 25·3% 
(1302/5147) were Grade 1, and the mean pathological size was 16·5mm (SD 12·1, n=5180). 
DCIS alone was present in 22·7% (1527/6717) of cancers, of which 63·1% (830/1316) had 
high grade, 27·1% (356/1316) had intermediate grade and 9·9% (130/1316) had low grade. For 
cancers with invasive disease present 76·7% (3909/5097) were axillary node negative, 17·3% 
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(884/5097) had one or two nodes involved, and only 6·0% (304/5097) had three or more nodes 
involved.  
 
Comparison between different Single and Double Reading 
The recall rate was 4·08% (32863/805206, 95% CI 4·04%-4·12%) after arbitration. In 
comparison, if there were no arbitration and women were recalled if either reader suggested it, 
the recall rate would be 6·19% (49857/805206, 95% CI 6·14%-6·24%). If there had been only 
single reading (the first reader decision only) then the recall rate would have been 4·76% 
(38295/805206, 95% CI 4·71%-4·80%), p<0·001). 
 There were 7055 cancers detected by the system of double reading plus arbitration. If 
there had been only single reading (the first reader decision only) then fewer cancers (n= 6425) 
would have been detected (test of two proportions p<0·001). The second reader detected an 
additional 627 cancers which were not detected by the first reader.  
The additional cancers detected by the second reader (which were not detected by the 
first reader) were less likely to contain invasive disease, 69·5% (417/600) were invasive in 
comparison to 78·0% (4770/6114, p<0·001). Where invasive disease was present, it was likely 
to be lower grade in the additional cancers detected by the second reader only, with 32·3% 
(134/415) low grade in comparison to 24·7% (1167/4729), and 14·9% (62/415) high grade in 
comparison to 20·9% (986/4729) (p<0·001). The mean pathological size of invasive tumours 
was smaller for the additional cancers detected by the second reader; 14·2mm (SD=10.6, 
n=416) for these additional cancers detected in comparison to 16·7mm (SD=12·2, n=4761) for 
cancers detected by the first reader (p<0·001). There were fewer nodes involved in invasive 
cancers detected by the second reader only, of these only 3·2% (13/406) had three or more 
involved nodes, and 12·6% (51/406) had 1-2 involved nodes in comparison to 6·2% (291/4688) 
with 3 or more involved nodes and 17·8% (833/4688) with 1-2 involved nodes in the invasive 
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cancers detected by the first reader (p<0·001). Figures 2 and 3 show example cases of small 
invasive cancer and DCIS detected by the second reader only.  
For cancers where DCIS only was present (no invasive disease) DCIS grade was lower 
in cancers detected by the second reader only, in comparison to those cancers detected by the 
first reader, with 56·9% (87/153) high grade in comparison to 63·9% (743/1163), and 17·0% 
(26/153) low grade in comparison to 8·9% (104/1163), (p=0·007). The sensitivity analysis 
assuming all missing data were extreme cases did not alter the overall results. 
We have follow-up data for 247,885 women, from 10 of the first centers to complete 
the trial. 210,525 attended a follow-up screen. The cancer detection rate overall for the follow-
up appointment was 9.7 per thousand women screened (2043/210525). The cancer detection 
rate for the follow up appointment was different in the following three groups: recall by the 
first reader but not by the second reader and arbitration at the current screen (16 per thousand 
women screened, 45/2800), recall by the second reader but not by the first reader and arbitration 
at the current screen (24 per thousand women screened, 47/1954) and all other women who 
were not recalled by either reader at the current screen (9.3 per thousand women screened, 
1839/198602, p<0.001). The three year interval cancer rate was 2.1 per thousand women 
screened (512/247885). The interval cancer rate was different in the following three groups: 
recall by the first reader but not by the second reader or arbitration at the current screen (5.5 
per thousand women screened, 18/3281), recall by the second reader but not by the first reader 
or arbitration at the current screen (6.1 per thousand women screened 14/2281), and all other 
women who were not recalled by either reader at the current  screen (1.9 per thousand women 
screened, 443/231937, p<0.001). If we were to assume all of the subsequent excess cancers 
(interval and three year follow up) in women who had a discordant read and were not recalled 
by arbitration were missed, and these same rates applied to the whole dataset, then there would 
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have been 752, (10.3%) cancers detected by the second reader only, in addition to 6,536 
detected by the first reader.  
 
Discussion 
In this large population-based cohort study nested within a trial we found that the addition of a 
second reader to interpret breast screening mammograms, plus arbitration of discordant 
examinations, reduced recall rate and increased cancer detection rate. The second reader 
detected an extra 627 (out of 7055, 8·9%) cancers not detected by the first reader, but these 
were smaller and lower grade, and less likely to be invasive or have involved nodes. These 
characteristics are indicative of earlier detection and potential benefit from less aggressive, 
more successful treatment, but are also suggestive of overdiagnosis of disease. Whilst 
overdiagnosis is more associated with smaller, lower grade, non-invasive disease without 
involved nodes, we cannot accurately predict which individual cancers will develop 
symptomatically.  
Previous studies using digital mammography found higher recall rates using double 
reading (4.8-4.9%) than single reading (4.6%) (23, 24). A recent analysis suggested that double 
reading may not be cost-effective (23). We found that with effective arbitration of discordant 
examinations a second reader can reduce recall rates, but a formal cost-benefit analysis would 
be needed to assess the incremental benefit of the time involved in the second round of 
interpretations is the optimal strategy. Previous digital mammography studies have been small, 
and detected no statistically significant difference in cancer detection rates, or the size, grade 
and types of cancer between single and double reading (22-24). Our study is an order of 
magnitude larger than these studies and indicates that the addition of a second reader increases 
cancer detection rates, although the additional cancers detected are smaller, and of a lower 
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grade and stage. The inconsistencies observed between ours and previous studies may reflect 
the greater statistical power of our study to detect small differences.  
Policy-makers routinely evaluate how to deliver breast screening in optimal ways. In 
France, a recommendation has been made to expand the use of second readers based on 
increased cancer detection (from older film mammography studies) and quality assurance (31). 
Conversely Spanish researchers have suggested that double reading may not be cost-effective 
(based on small digital mammography studies suggesting increased recall rates) (23). Our 
findings indicate an increase in cancer detection with a second reader using digital 
mammography, and that recall rates can be reduced with effective arbitration. To fully 
understand the difference in outcomes between screening programs using single or double 
reading requires an RCT. Future research may also investigate the effect of a second reader 
when using breast tomosynthesis.  
This study has limitations. First, some women recalled by one reader only received a 
reference standard of arbitration, only those recalled by arbitration received further testing, e.g. 
diagnostic biopsy. It is possible that some women not recalled by arbitration did have cancer 
that was not detected by this reference standard. In a study that predominantly employed film 
mammography, Hofvind and colleagues reported that the rate of interval cancers was higher 
amongst women who had discordant interpretations of their mammograms (ie where one reader 
recommended recall and the other did not) and were not recalled than amongst the whole 
screening population, 2.9/1000 vs. 1.7/1000 (32). Similarly, in our study, interval cancer rates 
were higher in women who were arbitrated and not recalled at the current round (6.1 per 
thousand women in those recalled by reader 2 only and 5.5 per thousand women in those 
recalled by reader 1 only) in comparison to other women not recalled at the current round (1.9 
per thousand women screened). Ascertainment of interval cancers is unlikely to be complete 
(particularly from year 3) due to delays in data transfer from the English cancer registries to 
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screening units. For the same groups of women who were arbitrated and not recalled at the 
current round we found a similar excess in cancer detection rates at the subsequent screening 
round. This excess may be due to a combination of cancers missed at the current screening 
round by arbitration, and cases with a discordant read having other characteristics associated 
with a higher risk of cancers developing between screening rounds such as increased breast 
density. If we assumed the excess was purely due to cancers missed by arbitration, then 10.3% 
of cancers would have been detected by reader 2 only. This is higher than the 8.9% we report, 
but it may be an overestimate due to the inclusion of cancers that have developed in the 
screening interval. Second, we assumed the actions of the first reader would be the same as a 
single reader. Readers working alone may operate at a different standard/recall threshold if 
there is no second reader to pick up missed cancers, and no arbitration to reduce false positive 
recalls. Third, whilst conducting this study in a trial setting minimised missing data, there 
remained some missing information about cancer characteristics. The sensitivity analysis 
assuming all missing data were extreme cases did not alter the overall results. Finally, whilst 
readers independently examine mammograms they could access the decision of the first reader 
by examining notes. This is not a normal part of reading in a busy population screening program 
but if it occurred would support our null hypothesis and underestimate the incremental value 
of a second reader (if second readers were aligning their results with that of the first reader, 
cancers detected by the second reader would not have different characteristics to those detected 
by the first reader). 
In conclusion, in this large population-based cohort study the use of a second reader 
plus arbitration in mammography reduces recall rates and improves cancer detection. The extra 
cancers detected are smaller and lower grade, and less likely to be invasive or have involved 
nodes. Detecting these extra cancers may be associated with detecting important pathology 
earlier, but it may also be associated with increased overdiagnosis from screening. Further 
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analysis of follow-up data on outcomes is required to understand the balance of benefits and 
harms of detecting these extra cancers. Policy-makers should consider the overall harms and 
benefits when deciding whether to use a second reader, bearing in mind that a single reader 
might not perform in the same way a first reader working as part of a team.   
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Table 1. Recall rates and characteristics of cancers detected for the system implemented in 
the UK (Double reading plus arbitration of disagreements) with comparison of characteristics 
of all cancers detected by the first reader, in comparison to the extra cancers detected by the 
second reader alone  
 
 
 
    
Double reading 
and Arbitration First Reader Recall 
Second Reader 
Recall only, not 
First Reader p-value 
Number of 
women   805206   805206   805206  
 
Women 
recalled   32863 (4·08%) 38295 (4·76%) 11562 (1·44%) 
 
Benign 
biopsies  8369 (1·04%) 7192 (0·89%) 1167 (0·14%) 
 
Cancers 
detected   7055 (0·88%) 6425 (0·80%) 627 (0·08%) 
 
           
Invasive 
Disease 
Present 
Yes 5190 (77·3%) 4770 (78·0%) 417 (69·5%)  
No 1527 (22·7%) 1344 (22·0%) 183 (30·5%) <0•001
a 
Not recorded 338   311   27    
Invasive 
Disease 
Grade  
  
Grade 3 1048 (20·4%) 986 (20·9%) 62 (14·9%)  
Grade 2 2797 (54·3%) 2576 (54·5%) 219 (52·8%) <0•001
b 
Grade 1 1302 (25·3%) 1167 (24·7%) 134 (32·3%)  
Not recorded 43   41   2    
Axillary 
Nodes 
Number 
Positive 
(Invasive 
Disease 
Present only) 
0 3909 (76·7%) 3564 (76·0%) 342 (84·2%)  
1-2 884 (17·3%) 833 (17·8%) 51 (12·6%) <0•001
c 
3+ 304 (6·0%) 291 (6·2%) 13 (3·2%)  
Not recorded 93   82   11   
 
         
Size of 
invasive 
cancer (mm) 
  
  
Number 5180   4761   416    
Mean (SD) 16·5 (12·1) 16·7 (12·2) 14·2 (10·6) <0•001
d 
Median 14   14   11    
Quartiles 9 20 9 20 8 17 
 
DCIS grade 
  High 830 (63·1%) 743 (63·9%) 87 (56·9%) 
 
 Intermediate 356 (27·1%) 316 (27·2%) 40 (26·1%) 0•007
e 
 Low 130 (9·9%) 104 (8·9%) 26 (17·0%)  
 None 2   2   0    
 Not recorded 209   179   30    
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Figure 1. Flow of women through the study. *Women whose mammograms were only 
reviewed by a single reader were excluded from further analysis 
 
Figure 2. Right sided 5mm invasive ductal not otherwise specified (NOS) grade 1 cancer, 
detected by the second reader only. Further tests indicated ER+ PR+ Her 2-, 0 of 3 axillary 
nodes sampled were positive. a. Right craniocaudal view b. Right mediolateral oblique view c. 
ultrasound.  
a.    b.   c. 
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Figure 3. Left sided 6 mm low grade Ductal Carcinoma in Situ (DCIS). a. Left mediolateral 
oblique view b. Left craniocaudal view c. left coned magnification of the microcalcification.  
a.                  b.    c. 
 
 
